Smoking and inflammation: Their synergistic roles in chronic disease

Current Cardiovascular Risk Reports

Volumn 2, Issue 6, 2008, Pages 446-451

  Halvorsen, Bente ^a   Otterdal, Kari ^b   Tonstad, Serena ^b   Aukrust, Pål ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651456099     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-008-0079-z     Document Type: Review

References (49)

1. Ambrose JA, Barua RS: The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004, 43: 1731-1737.
2. Howard G, Wagenknecht LE, Burke GL, et al.: Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998, 279: 119-124.
3. Kelly TN, Gu D, Chen J, et al.: Cigarette smoking and risk of stroke in the Chinese adult population. Stroke 2008, 39: 1688-1693.
4. Tonstad S, Andrew Johnston J: Cardiovascular risks associated with smoking: a review for clinicians. Eur J Cardiovasc Prev Rehabil 2006, 13: 507-514.
5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004, 83: 1-1438.
6. Gritz ER, Vidrine DJ, Fingeret MC: Smoking cessation a critical component of medical management in chronic disease populations. Am J Prev Med 2007, 33: S414-S422.
7. Glantz SA, Parmley WW: Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation 1991, 83: 1-12.
8. Law MR, Hackshaw AK: A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997, 315: 841-846.
9. Orosz Z, Csiszar A, Labinskyy N, et al.: Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am J Physiol 2007, 292: H130-H139.
10. Barnoya J, Glantz SA: Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005, 111: 2684-2698.
11. Pryor WA, Stone K: Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993, 686: 12-27; discussion 27-28.
12. Stedman RL: The chemical composition of tobacco and tobacco smoke. Chem Rev 1968, 68: 153-207.
13. Argacha JF, Adamopoulos D, Gujic M, et al.: Acute effects of passive smoking on peripheral vascular function. Hypertension 2008, 51: 1506-1511.
14. Mishra NC, Rir-Sima-Ah J, Langley RJ, et al.: Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. J Immunol 2008, 180: 7655-7663.
15. Koshi R, Sugano N, Orii H, et al.: Microarray analysis of nicotine-induced changes in gene expression in a macrophage-like human cell line. J Period Res 2007, 42: 518-526.
16. Kilaru S, Frangos SG, Chen AH, et al.: Nicotine: a review of its role in atherosclerosis. J Am Coll Surg 2001, 193: 538-546.
17. Xiao D, Huang X, Lawrence J, et al.: Fetal and neonatal nicotine exposure differentially regulates vascular contractility in adult male and female offspring. J Pharmacol Exp Ther 2007, 320: 654-661.
18. Lawrence J, Xiao D, Xue Q, et al.: Prenatal nicotine exposure increases heart susceptibility to ischemia/reperfusion injury in adult offspring. J Pharmacol Exp Ther 2008, 324: 331-341.
19. Glass CK, Witztum JL: Atherosclerosis. The road ahead. Cell 2001, 104: 503-516.
20. Bermudez EA, Rifai N, Buring JE, et al.: Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002, 89: 1117-1119.
21. Henderson B, Csordas A, Backovic A, et al.: Cigarette smoke is an endothelial stressor and leads to cell cycle arrest. Atherosclerosis 2008 Feb 29 (Epub ahead of print).
22. Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170: 191-203.
23. Marz W, Scharnagl H, Winkler K, et al.: Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation 2004, 110: 3068-3074.
24. Tonstad S, Sundfor T, Seljeflot I: Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease. Am J Cardiol 2005, 95: 1187-1191.
25. Halvorsen B, Lund Sagen E, Ueland T, et al.: Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease. Scand J Clin Lab Invest 2007, 67: 604-611.
26. Winkelmann BR, Boehm BO, Nauck M, et al.: Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease. Curr Med Res Opin 2001, 17: 132-141.
27. Zang LY, Stone K, Pryor WA: Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Rad Biol Med 1995, 19: 161-167.
28. Barua RS, Ambrose JA, Eales-Reynolds LJ, et al.: Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 2001, 104: 1905-1910.
29. Loscalzo J: Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001, 88: 756-762.
30. Nedeljkovic ZS, Gokce N, Loscalzo J: Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J 2003, 79: 195-199; quiz 198-200.
31. Casey RG, Joyce M, Roche-Nagle G, et al.: Young male smokers have altered platelets and endothelium that precedes atherosclerosis. J Surg Res 2004, 116: 227-233.
32. Chavez J, Cano C, Souki A, et al.: Effect of cigarette smoking on the oxidant/antioxidant balance in healthy subjects. Am J Therap 2007, 14: 189-193.
33. Schulze F, Lenzen H, Hanefeld C, et al.: Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination Investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 2006, 152: 493. e1-493. e8.
34. Rahman MM, Laher I: Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 2007, 5: 276-292.
35. Yanbaeva DG, Dentener MA, Creutzberg EC, et al.: Systemic effects of smoking. Chest 2007, 131: 1557-1566.
36. Hasnis E, Bar-Shai M, Burbea Z, Reznick AZ: Mechanisms underlying cigarette smoke-induced NF-kappaB activation in human lymphocytes: the role of reactive nitrogen species. J Physiol Pharmacol 2007, 58(Suppl 5): 275-287.
37. Lambert C, McCue J, Portas M, et al.: Acrolein in cigarette smoke inhibits T-cell responses. J Allergy Clin Immunol 2005, 116: 916-922.
38. Gajalakshmi V, Peto R, Kanaka TS, Jha P: Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003, 362: 507-515.
39. Klareskog L, Padyukov L, Alfredsson L: Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 2007, 19: 49-54.
40. Yokode M, Kita T, Arai H, et al.: Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc Nat Acad Sci U S A 1988, 85: 2344-2348.
41. Pech-Amsellem MA, Myara I, Storogenko M, et al.: Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis. Cardiovasc Res 1996, 31: 975-983.
42. Nishio E, Watanabe Y: Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols. Biochem Biophys Res Commun 1997, 236: 289-293.
43. Yamaguchi Y, Kagota S, Haginaka J, Kunitomo M: Evidence of modified LDL in the plasma of hypercholesterolemic WHHL rabbits injected with aqueous extracts of cigarette smoke. Environ Toxicol Pharmacol 2000, 8: 255-260.
44. St-Laurent J, Boulet L, Bissonnette EY: Five days exposure to cigarette smoke extract alters bronchial epithelial cells mediator secretion [abstract 54]. J Allergy Clin Immunol 2008, S14.
45. Le Quément C, Guenon I, Gillon JY, et al.: The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke. Br J Pharmacol 2008 154: 1206-1215.
46. Bakhru A, Erlinger TP: Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005, 2: e160.
47. Dobson AJ, Alexander HM, Heller RF, Lloyd DM: How soon after quitting smoking does risk of heart attack decline?J Clin Epidemiol 1991, 44: 1247-1253.
48. Meade TW, Imeson J, Stirling Y: Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987, 2: 986-988.
49. Tracy RP, Lemaitre RN, Psaty BM, et al.: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997, 17: 1121-1127.